XBP1-s can also bind to the ACGT core sequence of the IL-6 promoter and enhance its transcription, leading to the activation of the STAT3 signaling pathway and enhanced tumorigenesis of melanoma, hepatocarcinoma, and primary effusion lymphoma [34,105,108]. Here, XBP1 is linked to melanoma.